The company provides a comprehensive range of services that cover the entire genome using their experimental protocol and proprietary bioinformatics analysis. This allows for specific and accurate digital sequence output, which can be used for next-generation sequencing platforms, sequencing reagents, sequencing applications, genomic diagnostics, and bioinformatics. InKaryo Corp's services are designed to meet the needs of researchers, clinicians, and patients, and they are committed to providing the highest quality results in a timely and cost-effective manner. With a focus on innovation and customer satisfaction, InKaryo Corp is a leader in the field of cytogenetic analysis services.